Sarepta Therapeutics Completes Submission of New Drug Application Seeking Approval of Golodirsen (SRP-4053)
Sarepta Announces Agreement with Nationwide Children’s Hospital for Rights to its Gene Therapy Program
pharmaceutical investing Sarepta Therapeutics Announces Fourth Quarter 2017 and Full-Year 2017 Financial Results
Silver Hammer Announces Receipt of Updated and Revised Drill Permit for Upcoming Silverton Project Exploration Program in Nevada
Transition Metals Identifies Four New Polymetallic Showings at Pike Warden, Yukon, Including Samples Returning >10,000 ppm Silver and 3.4% Molybdenum
